Zurcher Kantonalbank (Zurich Cantonalbank) Neogenomics Inc Transaction History
Zurcher Kantonalbank (Zurich Cantonalbank)
- $39 Billion
- Q2 2025
A detailed history of Zurcher Kantonalbank (Zurich Cantonalbank) transactions in Neogenomics Inc stock. As of the latest transaction made, Zurcher Kantonalbank (Zurich Cantonalbank) holds 45,410 shares of NEO stock, worth $413,231. This represents 0.0% of its overall portfolio holdings.
Number of Shares
45,410
Previous 37,156
22.21%
Holding current value
$413,231
Previous $352,000
5.97%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding NEO
# of Institutions
308Shares Held
129MCall Options Held
1.17MPut Options Held
297K-
Black Rock Inc. New York, NY19.7MShares$179 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.1MShares$129 Million0.0% of portfolio
-
Greenhouse Funds Lllp Baltimore, MD7.43MShares$67.6 Million2.32% of portfolio
-
First Light Asset Management, LLC Edina, MN6.85MShares$62.3 Million7.69% of portfolio
-
State Street Corp Boston, MA5.11MShares$46.5 Million0.0% of portfolio
About NEOGENOMICS INC
- Ticker NEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 125,796,000
- Market Cap $1.14B
- Description
- NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...